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Abstract Cartilage damage affects a large population via
acute and chronic injury and disease. Since native cartilage
does not self-renew, cartilage tissue engineering has gained
traction as a potential treatment. However, a limiting factor
is that the primary cell type in cartilage, the articular
chondrocyte, tends to de-differentiate when grown on 2D
surfaces for in vitro expansion. Thus, 3D systems are being
developed and used to counter this loss of chondrogenic
capabilities. We hypothesize that a 3D matrix that can be
remodeled may be more supportive of the chondrogenic
phenotype of encapsulated articular chondrocytes than a 2D
surface and may allow for the re-differentiation of chon-
drocytes after 2D expansion. Hence, in this study, enzy-
matically degradable polyethylene glycol (PEG) hydrogels
containing two different protease degradable peptide seg-
ments, with different degradation rates, were tested in
combination with chondrogenic medium as a 3D in vitro
culture system to better recapitulate the native environment
of human articular chondrocytes (hACs). In addition, the
effect of incorporation of the integrin binding ligand Arg-
Gly-Asp (RGD) in the hydrogels was explored. Hydrogels
crosslinked with a slower degrading crosslinker and not
functionalized with RGD maintained hAC viability and led
to increased GAG production and chondrogenic gene
expression over time, suggesting that this system can initi-
ate hAC re-differentiation after 2D expansion.
Graphical abstract
1 Introduction
1.1 Reﬂection on career goals by Jennifer Patterson
While studying chemical engineering at Princeton Uni-
versity, I participated in a Research Experience for Under-
graduates program at MIT in the laboratory of Prof.
Jonathan King and did senior thesis research with Prof.
Michael Hecht, where I determined the morphology of
novel beta-sheet proteins. Afterwards, I worked in a start-up
company founded by Profs. Michael Cima and Linda
Grifﬁths to develop 3D printing for tissue engineering. As I
wanted an academic career, I went to the University of
* Jennifer Patterson
jennifer.patterson@kuleuven.be
1 Department of Materials Engineering, KU Leuven, Kasteelpark
Arenberg 44, P.O. box 2450, Leuven 3001, Belgium
2 Skeletal Biology and Engineering Research Center, KU Leuven,
O&N 1, Herestraat 49, P.O. box 813, Leuven 3000, Belgium
3 Prometheus, Division of Skeletal Tissue Engineering, KU Leuven,
O&N 1, Herestraat 49, P.O. box 813, Leuven 3000, Belgium
Washington for a PhD in bioengineering, which was sup-
ported by a NSF Graduate Research Fellowship, and
worked with Prof. Patrick Stayton on hyaluronic acid
hydrogels. During my studies, I read papers by Prof. Jeffrey
Hubbell that described modular PEG-peptide hydrogels and
decided that I wanted to work with them so I obtained a
postdoctoral fellowship from the Whitaker International
Program to go to the Hubbell lab at EPFL. In 2011, I started
as a tenure-track assistant professor in the Department of
Materials Engineering at KU Leuven to develop a research
line on materials-biology interface science. My group grew
to comprise two postdocs, six PhD students, and two master
students (Fig. 1) and was supported by four major project
grants and several individual fellowships totaling over €2
million. I also developed master-level courses on the host
response and ‘next generation’ biomaterials. In fall 2017 I
am starting a new position as CSO of BIOFABICS LDA, a
start-up company specialized in 3D biotissue analogues, but
hope to return to academia in the future.
1.2 Background and state of the art
Articular cartilage, also known as hyaline cartilage, is the
main load bearing tissue at synovial joints. To be able to
bear the load exerted on it and maintain its mechanical
durability, articular cartilage is comprised of a dense
extracellular matrix (ECM) that is primarily composed of
type II collagen, proteoglycans, and other noncollagenous
proteins, which are present to a lesser extent [1, 2]. These
components interact with each other to create a network that
helps entrap large amounts of water, which is vital for the
maintenance of the biomechanical functionality of the tissue
[3]. Although it is highly durable, articular cartilage, just
like other components of the body, is susceptible to damage
via everyday wear and tear, traumatic injury, and/or disease.
But, unlike other tissues, articular cartilage is avascular,
alymphatic, and aneural, and it contains a very sparse,
specialized cell population called chondrocytes. These
properties inhibit native cartilage from renewing itself when
damaged, leading to chronic pain, discomfort, and lowered
quality of life for patients. Therapies in the past, such as
alloplastic or allogenic implants, were successful to a cer-
tain extent but were limited by donor tissue availability and
donor site morbidity. More recently, surgical techniques
such as microfracture surgery or autologous chondrocyte
transplantation/implantation (ACT/ACI), although promis-
ing [4, 5], are marred by the size of the damage, ﬁbrous
cartilage formation with inferior mechanical properties, and
donor site morbidity [6]. Moreover, a limiting factor when
using ACT/ACI is that the harvested chondrocytes de-
differentiate into a ﬁbroblast-like cell type when expanded
in vitro on two dimensional (2D) surfaces to desired cell
numbers [7, 8]. To counteract this loss of chondrogenic
state of the chondrocytes, researchers have been investi-
gating several methods of culture in three dimensional (3D)
systems. It was ﬁrst shown using agarose gels that de-
differentiated chondrocytes can re-differentiate and regain
some of their phenotype under 3D conditions [8]. Since
then, to develop various 3D re-differentiation techniques
for articular chondrocytes, investigators have syste-
matically moved from seeding the cells on meshes and
scaffolds [9, 10] to embedding cells within constructs, pri-
marily hydrogels.
Hydrogels are an attractive scaffold choice for cartilage
damage repair as they are made up of large amounts of
water, thus mimicking the native ECM where chondrocytes
reside. Additionally, the hydrophilic nature of these
scaffolds facilitates nutrient transfer throughout the system.
Autologous chondrocytes combined with natural polymer
based hydrogels such as agarose [8, 11], alginate [12, 13],
hyaluronic acid [14, 15], and ﬁbrin [16, 17] have garnered
attention in the past due to their attractive in vivo/in
situ application and have subsequently demonstrated sufﬁ-
cient glycosaminoglycan (GAG) content and histological
evidence of cartilaginous tissue. Although the aforemen-
tioned natural polymer hydrogels have shown promising
results, controlling the mechanical properties and structural
integrity of these hydrogels while in culture in vitro
and the lack of uniformity of these hydrogels are a few of
the limitations that arise with these types of systems.
In particular, in vitro stability is a desired feature, thus
making a synthetic material, such as polyethylene glycol
(PEG), an attractive alternative. PEG, although inert,
can be combined with natural components such as matrix
metalloproteinase (MMP) sensitive peptide linkages or
Fig. 1 Research Group of Jennifer Patterson (March 2017, in front of
the Arenberg Castle on the engineering campus of the KU Leuven):
Front row: Dr. Jennifer Patterson, Dr. Susanna Piluso, Laurien Van
den Broeck, Jasper Timmerman, Dr. Soultan Al Halifa; Back row:
Rory Gibney, Burak Toprakhisar, Christian Garcia, Laurens Rutgeerts,
Ricardo Augusto, Abhijith Kudva
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other bioactive ligands, and these systems have demon-
strated increased bioactivity and proved advantageous for
tissue engineering purposes [18]. Hydrogels formed
from PEG macromers have been extensively studied and
characterized, and the different compositions that allow for
the controlled variation of properties such as stiffness,
degradation rate, and bioactivity have been thoroughly
demonstrated [19, 20]. Moreover, chondrocytes encapsu-
lated within PEG-based constructs have displayed promis-
ing results in the past. For instance, when bovine
chondrocytes were photo-encapsulated within PEG dime-
thacrylate (PEG-DM) 3D systems, they showed a pro-
pensity to produce collagen II and new ECM [20, 21].
Additionally, it was shown that the incorporation of
degradable linkages, in this case hydrolytically sensitive
poly(lactic acid) (PLA) segments, increased the extent of
collagen II production and the homogeneity of GAG
deposition by encapsulated bovine chondrocytes [20]. In
similar manner, researchers have shown that combining a
collagen mimetic peptide conjugate with a photo-
polymerized PEG system enhances chondrocyte ECM
production [22].
Hence, herein, a chemically crosslinked, protease sensi-
tive PEG vinyl sulfone (PEG-VS) system [18] was utilized
to encapsulate human articular chondrocytes (hACs), as a
3D system for the in vitro culture of hACs. In the past,
MMP sensitive synthetic polymer systems have been
investigated with primary bovine (calf) chondrocytes [23].
This study tested two different sized PEG-VS macromers
and further compared a MMP sensitive and a non-
degradable crosslinker. All of the systems maintained
bovine chondrocyte viability over time; however, the MMP
sensitive structures led to an increased expression of col-
lagen type II and aggrecan [23]. Building upon these results,
in the present study, the use of hACs improves the trans-
lational value of a MMP sensitive PEG matrix for future
cartilage tissue engineering applications, an aspect that is
vital to the ﬁeld of regenerative medicine. Furthermore, two
protease-degradable peptide segments with different kinetic
parameters [24] were tested in combination with and
without the integrin binding sequence, Arginine-Glycine-
Aspartic Acid (RGD), in a PEG hydrogel system for the
purpose of supporting the re-differentiation process of de-
differentiated chondrocytes that were previously expanded
in 2D culture.
2 Materials and methods
2.1 Articular chondrocyte cell culture
Frozen vials of hACs at passage 2 were acquired from the
Tissue Homeostasis and Disease (THD) Lab, part of the
Skeletal Biology and Engineering (SBE) Research Center,
at KU Leuven. The cells were isolated from the hips of
patients undergoing total hip replacement surgery. The
University Hospitals Leuven Ethics Committee and Bio-
bank Committee approved the study, and specimens were
taken with patients’ written consent. hACs were plated in
tissue culture ﬂasks with regular growth medium (GM)
(DMEM/F12 with 10% fetal bovine serum (FBS), 1%
antibiotics (AB), and 1% L-glutamine) and used at passage
5 for encapsulation within the 3D hydrogels.
2.2 Hydrogel preparation and cell encapsulation
6.5% (w/v) cell-laden PEG-vinyl sulfone (PEG-VS)
hydrogels were made via a Michael Type addition reaction
as previously described [18]. Brieﬂy, 20 kDa 4-arm PEG-
VS (JenKem) was dissolved in 0.3 M HEPES buffer, pH 8,
for a ﬁnal w/v percentage of 6.5%. Subsequently, the
adhesion binding peptide containing a free thiol (Ac-
GCGYGRGDSPG-NH2) was reacted with the PEG-VS for
a ﬁnal concentration of 150 µM within the 3D scaffold.
With regards to the hydrogels without RGD (0 µM), an
equal volume of buffer was added. Next, a trypsin released
hAC cell suspension (10× 106 cells/ml ﬁnal concentration)
was mixed with two different di-thiol, MMP sensitive
crosslinkers with different degradation rates [24]: Ac-
GCREGPQGIWGQERCG-NH2, referred to as the regular
degrading crosslinker (R), or Ac-GCRDVPMSMRGG
DRCG-NH2, referred to as the fast degrading crosslinker
(F). Finally, the PEG-VS solutions, with or without RGD
functionalization, were reacted with their corresponding
crosslinker and cell suspension. The hydrogel nomenclature
used throughout the remaining text is given in Table 1.
Hydrogel disks of approximately 1 mm in thickness and
about 8 mm in diameter were formed by sandwiching drops
of the hydrogel precursors between hydrophobic SigmaCote
(Sigma) treated slides with spacers and incubated for 30 min
at 37 °C in a humidiﬁed incubator. Peptides were purchased
from commercial suppliers (Biomatik or PeptideSynthetics)
Table 1 Hydrogel
nomenclature
Hydrogel abbreviation Hydrogel composition
R0 6.5% PEG+ Regular degrading crosslinker+ 0 μM RGD
RR 6.5% PEG+ Regular degrading crosslinker+ 150 μM RGD
F0 6.5% PEG+ Fast degrading crosslinker+ 0 μM RGD
FR 6.5% PEG+ Fast degrading crosslinker+ 150 μM RGD
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or were prepared by solid phase peptide synthesis and
puriﬁed via HPLC-MS.
2.3 Culture conditions
Cell-laden hydrogels were carefully removed from the slides
and placed in 24-well plates with regular GM for 24 h and
then switched to 4 C chondrogenic differentiation medium
[DMEM/F12 (Invitrogen) with 5% FBS, 1% AB, 10 ng/ml
TGF-β1 (PeproTech), 1× Insulin Transferin Selenium+
premix (ITS+ ; BD Biosciences), 100 nM dexamethasone,
and 100 µg/ml ascorbic acid] [25, 26], which was replenished
every 2–3 days. Samples were analyzed at 0 weeks (imme-
diately before switching to chondrogenic differentiation
medium) and after 1 week and 4 weeks in the chondrogenic
differentiation medium (Fig. 2).
2.4 Picogreen/QuanIT DNA quantiﬁcation
To investigate cell proliferation, the DNA content of three
hydrogels per condition and per time point was calculated
using the Picogreen DNA Quant-iT kit and the Qubit mea-
suring device (Invitrogen). The hydrogels were ﬁrst degraded
in digestion buffer composed of Proteinase-K (0.5mg/ml;
Sigma Aldrich), phosphate buffered EDTA (5mM EDTA in
PBS pH 7.1; PBE), and 0.1% Triton X-100 solution over-
night at 60 °C. Next, a working solution of the reagent was
prepared according to the instructions of the manufacturer.
The samples were read using the Qubit Fluorometer, and the
DNA concentration was calculated.
2.5 Cell viability assay
The viability of the encapsulated hACs within the different
PEG hydrogel constructs was analyzed using a Live/Dead
kit (Invitrogen). The hydrogels were washed with phosphate
buffered saline (PBS; Gibco) for 5–10 min. Next, a staining
solution of calcein AM and ethidium homodimer-1 (ETH-1)
in PBS was added to the wells and incubated at 37 °C for
30–45 min. The samples were then washed again in PBS
and imaged using an Olympus FluoView confocal micro-
scope with 10× objective at step size of 10 μm and a total
thickness of 500 μm. Imaris software was used to quantify
the images in the 3D view, and all images are represented as
the maximum intensity of the z-stack.
2.6 DMMB GAG assay
The GAG production was analyzed using the dimethyl-
methylene blue (DMMB) GAG assay. At each time point,
the same digested samples used in the DNA assay were
used for the DMMB assay to quantify GAG/DNA. Brieﬂy,
1,9–dimethylmethylene blue chloride (Sigma) was dis-
solved in ethanol overnight and then added to a sodium
chloride (0.04 M NaCl)/glycine solution, pH 3, for a ﬁnal
concentration of 46 μM DMMB. The solution was ﬁltered,
and the absorbance at 525 nm was measured to be 0.314
OD. Next, a serial dilution of chondroitin sulfate (CS;
Sigma), ranging from 0 to 100 µg/ml, was prepared using
PBE. Finally, 30 μl of the samples or the CS standards was
loaded into a 96-well plate, along with 270 μl of the DMMB
dye solution, and the absorbance was read at 570 nm. The
GAG concentration was calculated using the standard curve
generated from the serial dilution of CS, and then divided
by its corresponding DNA content to calculate GAG/DNA
(µg/pg).
2.7 RNA extraction and quantitative PCR for
chondrogenic markers
The total RNA from the hydrogels was isolated using a
trizol/ethanol/chloroform RNA extraction method and
quantiﬁed using a NanoDrop ND-1000 spectrophotometer
(Thermo Scientiﬁc). Subsequently, 500 ng of RNA was
converted into complementary DNA (cDNA) with Oligo
(dT) 18 primer using the RevertAid Hminus First Strand
cDNA Kit (Fermentas). SYBR Green (Applied Biosystems)
primers and a Rotor-Gene sequence detector were used for
qPCR of chondrogenic gene markers such as SOX-9,
aggrecan (ACAN), and type II collagen (COL2A). At each
time point, each independent triplicate sample was mea-
sured in duplicate. Relative expression was calculated using
the 2-ΔCT method, normalized to the house keeping gene,
hypoxanthine-guanine phosphoribosyltransferase-1 (HPRT-1).
2.8 Statistical analysis
Quantitative results in all text and ﬁgures are expressed as
mean ± standard deviation. For the DNA quantiﬁcation,
GAG production, and chondrogenic gene expression, a two-
way ANOVA was performed using hydrogel composition
and time as variables. Results were considered signiﬁcant
Fig. 2 Schematic representation showing the culture conditions and experimental time points
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with p-values below 0.05 (*p < 0.05; **p< 0.01; ***p<
0.001).
3 Results
3.1 Hydrogel composition inﬂuences hAC proliferation
but not viability over time
The DNA content of the various constructs was analyzed to
observe the effect of hydrogel composition on the pro-
liferation of the encapsulated hACs. When looking at the
DNA content (Fig. 3) of the hydrogels after 24 h of culture
in GM, the hydrogels did not demonstrate a signiﬁcant
difference in DNA content, thus indicating non-biased cel-
lular encapsulation. Furthermore, after being switched to the
4 C chondrogenic medium for 1 week, the DNA content of
the hydrogels did not indicate a signiﬁcant difference from
week 0 nor was there a signiﬁcant difference among the
different hydrogel compositions. However, after 4 weeks of
culture, the hAC cell numbers increased signiﬁcantly (p<
0.001) in three out of the four hydrogel compositions,
compared to both 0 and 1 weeks, indicating cellular pro-
liferation within these formulations over time. Only the
hydrogels composed of the regular crosslinker and not
functionalized with RGD did not demonstrate a signiﬁcant
increase in DNA content over time. Morever, at the 4 week
time point, this same hydrogel composition demonstrated a
signiﬁcantly lower amount of DNA not only when com-
pared to its counterpart functionalized with the integrin
binding sequence RGD (p< 0.001) but also when compared
to both faster degrading hydrogel formulations (p< 0.001).
Interestingly, the hydrogels with the faster degrading
crosslinkers displayed a higher DNA content after 4 weeks
of in vitro culture than the hydrogels composed of the
regular degrading crosslinker. The hydrogels composed of
the faster degrading crosslinker and not functionalized with
RGD displayed the highest increase in DNA content over
time as well as the highest amount of DNA content com-
pared to the other formulations (p< 0.001).
When observing the viability of the hACs in the 3D PEG
hydrogels (Fig. 4), the cells were able to stay alive
throughout the 4 weeks of the study. More speciﬁcally, after
24 h of culture in GM, the hACs maintained a viability of>
90% in all the hydrogels (Fig. 4a). Next, when looking at the
cell-laden hydrogel constructs that were cultured in 4 C
chondrogenic medium for one week, the hACs demonstrated
a slight drop in viability to approximately 75% in the dif-
ferent hydrogel constructs. Additionally, the cells encapsu-
lated in the RGD containing hydrogel constructs showed a
slightly more spread morphology (Fig. 4b) compared to the
hACs within hydrogels without RGD, which was expected
due to the presence of the cell adhesive ligand. Lastly, after
4 weeks of in vitro culture in 4 C chondrogenic medium, the
hACs continued to demonstrate a viability of ~70%, an
indication that the selected protease-degradable PEG hydro-
gels are not harmful to the enapculated hACs over time.
3.2 GAG production by hACs increases after 3D in vitro
culture in chondrogenic medium
The re-differentiation of the encapsulated hACs was
observed in the 3D PEG hydrogels via the increase in GAG
production over time (Fig. 5). More speciﬁcally, the GAG
content, normalized to DNA content, demonstrated a dra-
matic increase in all the hydrogels after in vitro culture in
chondrogenic medium. When looking at the GAG produc-
tion of the encapsulated hACs after 24 h in GM, there was
little to no GAG present. Furthermore, at week 0, no sig-
niﬁcant difference among the different hydrogel groups was
observed, as expected. Already at 1 week, there was a
signiﬁcant increase in GAG content compared to 0 weeks
for all the groups (p< 0.001). Although the constructs did
not demonstrate an increase in DNA content at this time
point, the cells were producing more GAG when cultured in
the chondrogenic conditions. Moreover, the hACs encap-
sulated within the hydrogel composed of the faster
degrading crosslinker and no RGD produced signiﬁcantly
more GAG per cell compared to the cells within the other
hydrogel groups (p< 0.05). Besides this, there was no other
signiﬁcant difference observed among the hydrogel com-
positions at 1 week. On the other hand, after 4 weeks of
in vitro culture in chondrogenic medium, all the hydrogel
compositions displayed a 5×–7× increase in new GAG
Fig. 3 DNA quantiﬁcation of encapsulated hACs within protease
degradable PEG hydrogels, with and without RGD, and cultured over
4 weeks. Constructs were analyzed at 0 weeks (immediately before
switching to chondrogenic medium) and after 1 week and 4 weeks in
the 4 C chondrogenic differentiation medium. Results are presented as
mean± standard deviation (n= 3, *** p< 0.001; #R0 p< 0.001 when
comparing to R0; §F0 p< 0.001 when comparing to F0)
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production per cell by the hACs within, which was sig-
niﬁcantly higher than the GAG production at both 0 and
1 weeks (p< 0.001). This demonstrates the effect that 3D
culturing systems have on GAG production by hACs.
Additionally, at 4 weeks, the trend in GAG production is
the opposite of that for the DNA content of the constructs.
The hydrogels comprised of the regular degrading cross-
linker seem to allow the encapsulated hACs to produce
signiﬁcantly more GAG per cell (p< 0.05) than the cells
within the hydrogels with the faster degrading crosslinker.
Speciﬁcally, the hACs in the hydrogels with the regular
crosslinker that were not functionalized with RGD dis-
played the highest amount of GAG per DNA compared not
only to the hACs in the regular degrading hydrogel with
RGD but also to hACs in the faster degrading hydrogel
formulations (p< 0.01). This was the same hydrogel com-
position that displayed the lowest DNA content.
3.3 Recovery of hAC chondrogenic gene expression in a
3D environment
Lastly, the chondrogenic gene expression of the encapsu-
lated hACs in the 3D hydrogels demonstrated a signiﬁcant
increase over time, an indication that re-differentiation was
taking place (Fig. 6). SOX-9 (Fig. 6a), an early marker for
chondrogenesis, demonstrated no signiﬁcant difference
among the various hydrogel formulations at 0 weeks, in
addition to relatively low expression levels. After 1 week of
in vitro culture, the hACs cultured in the constructs with the
regular crosslinker and with no RGD witnessed a signiﬁcant
upregulation in SOX-9 expression levels compared to the
hACs within the other hydrogels (p< 0.05). This was also
Fig. 5 GAG production normalized to DNA content by hACs within
protease degradable hydrogels, with and without RGD, cultured over
4 weeks. Constructs were analyzed at 0 weeks (immediately before
switching to chondrogenic medium) and after 1 week and 4 weeks in
the 4 C chondrogenic differentiation medium. Results are presented as
mean± standard deviation (n= 3, *p< 0.05, **p< 0.01, *** p<
0.001)
Fig. 4 hAC viability within protease degradable PEG hydrogels, with
and without RGD, cultured over 4 weeks. Constructs were analyzed at
0 weeks (immediately before switching to chondrogenic medium) and
after 1 week and 4 weeks in the 4 C chondrogenic differentiation
medium. a Quantiﬁcation of the viability of hACs encapsulated in
hydrogels using IMARIS software (n= 1). Values given are the
average of three different areas measured within one sample. b
Representative images of Live/Dead staining via calcein AM (green,
live cells) and ethidium homodimer-1 staining (red, dead cells).
Confocal images are depicted as the maximum intensity of a 500 µm z-
stack that was acquired using a 10× objective (scale bar= 200 µm)
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signiﬁcantly higher than at 0 weeks (p< 0.01). After
4 weeks of culture, the hACs displayed a drop in SOX-9
expression levels within the hydrogels comprised of the
regular crosslinker and no RGD compared to its 1 week
counterpart (p< 0.001), while displaying relatively little
change in the other hydrogel formulations. Moreover, at the
4 week time point, the hACs within the constructs with the
regular crosslinker and functionalized with RGD displayed
the highest expression of SOX-9 compared to the cells
cultured in the other compositions (p< 0.01). Additionally,
the hACs demonstrated a general increase in ACAN (Fig.
6b) gene expression over time within the 3D constructs. The
cells cultured in the hydrogels with the regular crosslinker
and no RGD had a signiﬁcant upregulation of ACAN gene
expression already by 1 week (p< 0.001) and maintained
this higher level of expression at 4 weeks (p< 0.001).
Moreover, at 1 and 4 weeks, the cells cultured in these
hydrogels displayed a signiﬁcantly higher expression than
the cells cultured in the rest of the hydrogel groups (p<
0.05 at 1 week, p< 0.01 at 4 weeks). Finally, the COL2A
(Fig. 6c) gene expression levels of the encapsulated hACs
further support the above data indicating re-differentiation
taking place. There was a signiﬁcant increase (p< 0.001) in
relative gene expression of COL2A from 0 to 1 week of
in vitro culture, but there was no difference observed among
the different hydrogel formulations. This similar trend was
observed at 4 weeks, where the COL2A expression by the
hACs witnessed an even greater increase in all the hydrogel
formulations (p< 0.001), but there was no signiﬁcant dif-
ference observed among the various formulations.
4 Discussion
With this study, we were able to demonstrate the use of an
enzymatically degradable PEG hydrogel to maintain the
Fig. 6 Chondrogenic gene expression of hACs within protease
degradable hydrogels, with and without RGD, cultured over 4 weeks.
Constructs were analyzed at 0 weeks (immediately before switching to
chondrogenic medium) and after 1 week and 4 weeks in the 4 C
chondrogenic differentiation medium. Gene expression was calculated
relative to the housekeeping gene, HPRT. a SOX-9; b ACAN; c
COL2A. Results are presented as mean± standard deviation (n= 3, *p
< 0.05, **p< 0.01, *** p< 0.001)
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viability and initiate the re-differentiation process of
encapsulated de-differentiated hACs. Hydrogels containing
the MMP sensitive, regular degrading crosslinker and not
functionalized with RGD helped preserve hAC viability
over 4 weeks but did not promote proliferation. Meanwhile,
the hACs encapsulated in these same hydrogels exhibited
higher GAG production and higher chondrogenic gene
expression throughout the study. The recapitulation of the
chondrogenic phenotype of de-differentiated chondrocytes
in a 3D system after being cultured in 2D monolayers has
been investigated in the past, most commonly in alginate
beads or pellet cultures [27]. Moreover, it is well accepted
that chondrocytes favor a 3D system over 2D in vitro cul-
ture as this more closely resembles their native environment
[8, 28]. More speciﬁcally, the results gathered herein align
well with previous research conducted on different PEG
systems with both bovine [23] and human chondrocytes
[29], where the particular 3D constructs used maintained
chondrocyte viability and enhanced GAG production
depending on the hydrogel composition.
While the hydrogels with the regular degrading cross-
linker and without RGD performed the best here, all com-
positions of MMP sensitive PEG based hydrogels in this
study maintained the viability of the encapsulated hACs
over time. Additionally, the high viability observed at the
0 week time point indicates that the hACs remained viable
when being incorporated into the 3D network and thus
demonstrates that the hydrogel formation methodology in
and of itself does not have any adverse effect on the via-
bility of the hACs. In this way, the chemically crosslinked
PEG hydrogels, which are formed at close to physiological
pH [20], address a possible limitation of photo-crosslinked
3D systems [21], which often use cytotoxic photo-initiators
and/or exposure to UV light.
The hACs, when embedded within the different hydro-
gels at a cellular density of 10× 106 cells/ml, did not
demonstrate a signiﬁcant increase in the DNA content until
4 weeks. This could be an indication that the encapsulated
cells were still adjusting to their new 3D environment and
thus not proliferating at the early time point, similar to what
has been observed when hACs were cultured in alginate
beads or in pellets [27]. The increase in DNA content at the
later time point is also similar to that observed in studies
where bovine articular chondrocytes photo-encapsulated in
PEG hydrogels did not proliferate until after 4 weeks of
culture time [19]. At the 4 week time point, the higher
amount of DNA content in the hydrogels incorporating the
faster degrading crosslinker is probably due to its faster
degradation rate [24], which also correlates with previous
studies using bovine chondrocytes in MMP sensitive, che-
mically crosslinked PEG systems [23] and in PEG co-block
polymer based hydrogels [19, 20]. These studies showed
not only that a degradable construct is favorable over a non-
degradable one [23] but also that DNA content increased in
constructs comprising a higher proportion of degradable
components [19]. Interestingly, they also demonstrated that
these same systems produced more GAG over time [19], a
trend that was different within our investigations.
When looking at the GAG production, the low amounts
of GAG at the 0 week time point indicate the de-
differentiated state of the hACs due to the prior 2D cul-
ture. The hACs were released from the 2D ﬂasks and used
at passage 5 to ensure that hACs had indeed undergone de-
differentiation and had gradually lost their characteristic
molecular markers [30]. Although there was an increase in
GAG content after 1 week, the biggest increase occurred
after 4 weeks of culture. The correlation between the GAG/
DNA content and the DNA results was different from what
was observed in the above mentioned study by Bryant et al.,
which demonstrated that the faster degrading systems
allowed the cells to proliferate more and produce more
GAG over time [20]. Here, the constructs with the higher
DNA content at 4 weeks, mainly the faster degrading
hydrogels, displayed a lower amount of GAG production
per cell, whereas the constructs with the regular degrading
crosslinker demonstrated higher amounts of GAG. More
speciﬁcally, cells encapsulated in the regular degrading
hydrogel without RGD produced the highest amount of
GAG/DNA. One possible explanation for this result could
be due to the fact that the hACs prefer anchorage inde-
pendent growth and re-differentiation [8] and thus, once
placed within this environment, acclimated themselves and
produced more GAG and laid down new ECM. On the
other hand, the hydrogels containing RGD enabled the cells
to have a spread morphology, thus inhibiting the chondro-
genic process, a trend that was also seen when RGD was
incorporated within agarose hydrogels [31].
Additionally, the overall low expression levels of the
chondrogenic genes SOX-9, ACAN, and COL2A at 0 weeks
and the general increase over time of these markers
demonstrated that the hACs were in fact de-differentiated,
which is consistent with reports of the 2D culture of these
cells [32, 33], and that the cells were starting the re-
differentiation process. Both studies demonstrated the loss
of gene expression, especially for ACAN and COL2A, of
serially passaged hACs [32, 33]. In the present study, SOX-
9 displayed a signiﬁcant upregulation already at 1 week for
cells in the regular degrading hydrogel without RGD as well
as a drop in the expression at the 4 week time point. This ﬁts
with the status of SOX-9 as an early marker for chon-
drogenesis, especially during cellular condensation and in
differentiated chondrocytes [34, 35]. The signiﬁcantly
higher ACAN expression levels over time by the hACs in
the regular degrading hydrogels without RGD further vali-
dated this as the hydrogel of preference for new GAG
production. Taken together with the SOX-9 expression and
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GAG/DNA data, these results suggest that the hACs may be
undergoing the early stages of chondrogenesis at 1 week
and are beginning to lay down their own matrix, especially
in the regular degrading hydrogels without RGD. Lastly, the
signiﬁcant increase in COL2A expression from 0 to 1 to
4 weeks helps cement the idea that these enzymatically
degradable PEG-VS hydrogel systems do indeed initiate the
recovery/re-differentiation of hACs after they have under-
gone de-differentiation during 2D culture.
Chondrocytes, whether of animal or human origin, have
been investigated in 3D hydrogels for an extended period of
time. The enzymatically degradable PEG system used
within this study, in particular the regular degrading
hydrogel without RGD, is similar to the hydrogels used
with bovine chondrocytes by Park et al. [23]. However,
whereas they compared a degradable to a non-degradable
PEG hydrogel with different elastic moduli depending on
the size of PEG macromers used (4.5 and 13.5 kPa with a 4-
arm PEG and an 8-arm PEG macromer, respectively) [23],
in this study we tested two different proteolytically
degradable peptides, with different kcat values, incorporated
within PEG hydrogels with or without RGD, thus adding an
additional dimension. The regular degrading peptide
crosslinker, Ac-GCREGPQGIWGQERCG-NH2, had kcat
values of 0.65± 0.13 s−1 and 2.17± 0.16 s−1 with the
enzymes MMP-1 and MMP-2, respectively [24]. The fast
degrading peptide crosslinker, Ac-GCRDVPMSMRGG
DRCG-NH2, had signiﬁcantly higher kcat values of 5.25±
0.95 s−1 and 4.82± 0.79 s−1 with the enzymes MMP-1 and
MMP-2, respectively [24]. This difference in degradation rate
of the peptide crosslinkers will also affect the relative
mechanical properties of the hydrogels over time. While the
starting hydrogels have similar storage moduli independent
of the speciﬁc sequence of the peptide crosslinker (unpub-
lished data), the difference in degradation rates will lead to
hydrogels with different mechanical properties at later time
points in the experiment. The differences that arise over time
due to the two different crosslinkers in the hydrogel struc-
tures must be further investigated in future studies. Moreover,
although different hydrogel formulations were preferred by
the hACs for proliferation on the one hand and GAG pro-
duction/gene expression on the other, in both cases the
hydrogels did not contain RGD, further validating that hACs,
once placed in a 3D structure, prefer a non-adherent envir-
onment. Although some of the results herein align them-
selves with prior studies, the inconsistencies can potentially
be attributed to the fact the hydrogels used here and in the
previous investigations are not composed of the exact same
formulations. This further indicates the complexity of the
factors that can inﬂuence chondrocyte phenotype, ECM
synthesis, etc. In future work, a systematic design of
experiments approach could help to elucidate the effects that
the various factors have on chondrocyte in vitro culture.
5 Conclusion
Overall, this study demonstrates that the selected protease-
degradable, functionalized PEG hydrogels provide a sui-
table environment for the hACs to initiate re-differentiation
and regain evidence of a chondrogenic phenotype.
Although similar MMP-sensitive PEG hydrogels have
demonstrated positive results when combined with bovine
chondrocytes, herein we further highlight the system’s use
as an in vitro system for hACs, taking it one step closer to
translational/clinical relevance. The hydrogels that con-
tained the regular degrading crosslinker and no RGD
seemed to be the most appropriate scaffold for the hACs to
recapture their chondrogenic capabilities in vitro. Although
these hydrogels did not exhibit a signiﬁcant increase in
DNA content and thus failed to promote proliferation of
hACs, they still helped to maintain the viability of the
hACs, supported increased GAG production per cell over
time, and led to increased expression of the chondrogenic
markers SOX-9, ACAN, and COL2A.
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